Stockreport

Relmada Therapeutics CEO & Director Acquires 69% More Stock [Yahoo! Finance]

Relmada Therapeutics, Inc.  (RLMD) 
NASDAQ:AMEX Investor Relations: ir.relmada.com
PDF We reckon that's a good sign, especially since the purchase boosted their holding by 69%. Check out our latest analysis for Relmada Therapeutics The Last 12 Months O [Read more]